Adam A. Markovitz

511 total citations
23 papers, 383 citations indexed

About

Adam A. Markovitz is a scholar working on Economics and Econometrics, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Adam A. Markovitz has authored 23 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 17 papers in General Health Professions and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Adam A. Markovitz's work include Healthcare Policy and Management (16 papers), Primary Care and Health Outcomes (11 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Adam A. Markovitz is often cited by papers focused on Healthcare Policy and Management (16 papers), Primary Care and Health Outcomes (11 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Adam A. Markovitz collaborates with scholars based in United States, Taiwan and Cyprus. Adam A. Markovitz's co-authors include Andrew M. Ryan, John Z. Ayanian, John M. Hollingsworth, Ehud Grossman, Ari Shamis, Phyllis Yan, Yehonatan Sharabi, Naomi Nussinovitch, Edward C. Norton and Devraj Sukul and has published in prestigious journals such as Annals of Internal Medicine, BMJ and Journal of General Internal Medicine.

In The Last Decade

Adam A. Markovitz

22 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam A. Markovitz United States 11 188 174 75 56 52 23 383
Arun Mohan United States 12 39 0.2× 98 0.6× 44 0.6× 66 1.2× 29 0.6× 19 317
Anping Chang United States 8 50 0.3× 28 0.2× 153 2.0× 12 0.2× 56 1.1× 15 303
Eindra Aung Australia 10 15 0.1× 72 0.4× 15 0.2× 72 1.3× 93 1.8× 20 262
Georgios Gkountouras United Kingdom 10 107 0.6× 101 0.6× 34 0.5× 123 2.2× 78 1.5× 15 473
Philippa Boulle Switzerland 10 24 0.1× 136 0.8× 14 0.2× 51 0.9× 110 2.1× 20 389
Welcome Wami United Kingdom 11 17 0.1× 58 0.3× 13 0.2× 22 0.4× 32 0.6× 17 269
David J. Heller United States 12 153 0.8× 72 0.4× 153 2.0× 64 1.1× 55 1.1× 26 519
Janet Voûte India 4 34 0.2× 84 0.5× 63 0.8× 26 0.5× 39 0.8× 5 321
Joshua W. Devine United States 8 89 0.5× 38 0.2× 29 0.4× 14 0.3× 57 1.1× 23 302

Countries citing papers authored by Adam A. Markovitz

Since Specialization
Citations

This map shows the geographic impact of Adam A. Markovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam A. Markovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam A. Markovitz more than expected).

Fields of papers citing papers by Adam A. Markovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam A. Markovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam A. Markovitz. The network helps show where Adam A. Markovitz may publish in the future.

Co-authorship network of co-authors of Adam A. Markovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Adam A. Markovitz. A scholar is included among the top collaborators of Adam A. Markovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam A. Markovitz. Adam A. Markovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markovitz, Adam A., Pedro Gozalo, & Andrew M. Ryan. (2025). Participation and attrition in the Medicare Shared Savings Program. Health Affairs Scholar. 3(4). qxaf067–qxaf067.
2.
Ryan, Andrew M. & Adam A. Markovitz. (2023). Estimated Savings From the Medicare Shared Savings Program. JAMA Health Forum. 4(12). e234449–e234449. 7 indexed citations
3.
Markovitz, Adam A., et al.. (2022). Comprehensive Primary Care Plus Did Not Improve Quality Or Lower Spending For The Privately Insured. Health Affairs. 41(9). 1255–1262. 6 indexed citations
4.
Markovitz, Adam A., et al.. (2022). Hispanic-White Differences in Double Bonuses for Quality of Care in Medicare Advantage. JAMA Health Forum. 3(3). e215281–e215281. 1 indexed citations
5.
Markovitz, Adam A., et al.. (2021). Medicare Advantage Plan Double Bonuses Drive Racial Disparity In Payments, Yield No Quality Or Enrollment Improvements. Health Affairs. 40(9). 1411–1419. 9 indexed citations
6.
Markovitz, Adam A., John Z. Ayanian, Devraj Sukul, & Andrew M. Ryan. (2021). The Medicare Advantage Quality Bonus Program Has Not Improved Plan Quality. Health Affairs. 40(12). 1918–1925. 17 indexed citations
7.
Kerr, Eve A., Mandi L. Klamerus, Adam A. Markovitz, et al.. (2020). Identifying Recommendations for Stopping or Scaling Back Unnecessary Routine Services in Primary Care. JAMA Internal Medicine. 180(11). 1500–1500. 17 indexed citations
8.
Markovitz, Adam A., Michael Rozier, Andrew M. Ryan, et al.. (2019). Low-Value Care and Clinician Engagement in a Large Medicare Shared Savings Program ACO: a Survey of Frontline Clinicians. Journal of General Internal Medicine. 35(1). 133–141. 9 indexed citations
9.
Markovitz, Adam A., John M. Hollingsworth, John Z. Ayanian, et al.. (2019). Risk Adjustment In Medicare ACO Program Deters Coding Increases But May Lead ACOs To Drop High-Risk Beneficiaries. Health Affairs. 38(2). 253–261. 24 indexed citations
10.
Markovitz, Adam A., John M. Hollingsworth, John Z. Ayanian, et al.. (2019). Performance in the Medicare Shared Savings Program After Accounting for Nonrandom Exit. Annals of Internal Medicine. 171(1). 27–36. 28 indexed citations
11.
Sukul, Devraj, Andrew M. Ryan, Phyllis Yan, et al.. (2019). Cardiologist Participation in Accountable Care Organizations and Changes in Spending and Quality for Medicare Patients With Cardiovascular Disease. Circulation Cardiovascular Quality and Outcomes. 12(9). e005438–e005438. 10 indexed citations
12.
Sinha, Shashank S., Andrew M. Ryan, Adam A. Markovitz, et al.. (2018). The Effect of Medicare Accountable Care Organizations on Early and Late Payments for Cardiovascular Disease Episodes. Circulation Cardiovascular Quality and Outcomes. 11(8). e004495–e004495. 6 indexed citations
13.
Markovitz, Adam A., et al.. (2017). Incremental effects of antihypertensive drugs: instrumental variable analysis. BMJ. 359. j5542–j5542. 12 indexed citations
14.
Markovitz, Adam A., Chandy Ellimoottil, Devraj Sukul, et al.. (2017). Risk Adjustment May Lessen Penalties On Hospitals Treating Complex Cardiac Patients Under Medicare’s Bundled Payments. Health Affairs. 36(12). 2165–2174. 23 indexed citations
15.
Markovitz, Adam A., et al.. (2017). An Examination of Deintensification Recommendations in Clinical Practice Guidelines. JAMA Internal Medicine. 178(3). 414–414. 14 indexed citations
16.
Markovitz, Adam A., Rob Holleman, Timothy P. Hofer, et al.. (2017). Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs. Health Services Research. 52(6). 1996–2017. 10 indexed citations
17.
Markovitz, Adam A., Patricia P. Ramsay, Stephen M. Shortell, & Andrew M. Ryan. (2017). Financial Incentives and Physician Practice Participation in Medicare's Value‐Based Reforms. Health Services Research. 53(S1). 3052–3069. 8 indexed citations
18.
Markovitz, Adam A., Amanda M. Simanek, Robert H. Yolken, et al.. (2014). Toxoplasma gondii and anxiety disorders in a community-based sample. Brain Behavior and Immunity. 43. 192–197. 64 indexed citations
19.
Li, Linda, et al.. (2014). Facilitating Facilitation: How to Promote Active Learning. MedEdPORTAL. 1 indexed citations
20.
Sharabi, Yehonatan, et al.. (2006). Efficacy of Add-On Aldosterone Receptor Blocker in Uncontrolled Hypertension. American Journal of Hypertension. 19(7). 750–755. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Mohan Breakdown of academic impact, for papers by Anping Chang Breakdown of academic impact, for papers by Eindra Aung Breakdown of academic impact, for papers by Georgios Gkountouras Breakdown of academic impact, for papers by Philippa Boulle Breakdown of academic impact, for papers by Welcome Wami Breakdown of academic impact, for papers by David J. Heller Breakdown of academic impact, for papers by Janet Voûte Breakdown of academic impact, for papers by Joshua W. Devine
Rankless by CCL
2026